First Horizon Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Horizon Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$58.2K	Buy	241 +8	+3%	+$1.89K	﹤0.01%	920
2025 Q1	$56.7K	Sell	233 -3	-1%	-$902	﹤0.01%	875
2024 Q4	$77.5K	Sell	236 -14	-6%	-$4.75K	﹤0.01%	777
2024 Q3	$83.6K	Sell	250 -21	-8%	-$6.67K	﹤0.01%	784
2024 Q2	$74K	Sell	271 -129	-32%	-$37.5K	﹤0.01%	768
2024 Q1	$138K	Buy	400 +5	+1%	+$1.64K	﹤0.01%	600
2023 Q4	$128K	Buy	395 +26	+7%	+$8.15K	﹤0.01%	595
2023 Q3	$132K	Buy	369 +11	+3%	+$4.24K	﹤0.01%	559
2023 Q2	$136K	Sell	358 -28	-7%	-$11.4K	﹤0.01%	563
2023 Q1	$185K	Buy	386 +3	+0.8%	+$1.4K	0.01%	489
2022 Q4	$161K	Buy	383 +28	+8%	+$11.3K	0.01%	502
2022 Q3	$147K	Sell	355 -167	-32%	-$83.3K	0.01%	510
2022 Q2	$257K	Buy	522 +317	+155%	+$165K	0.01%	426
2022 Q1	$115K	Sell	205 -38	-16%	-$22.9K	0.01%	467
2021 Q4	$183K	Buy	243 +23	+10%	+$17.2K	0.01%	519
2021 Q3	$164K	Buy	220 +15	+7%	+$11.2K	0.01%	544
2021 Q2	$132K	Hold	205	–	–	0.01%	477
2021 Q1	$116K	Buy	205 +5	+3%	+$2.96K	0.01%	467
2020 Q4	$117K	Hold	200	–	–	0.01%	399
2020 Q3	$103K	Hold	200	–	–	0.01%	397
2020 Q2	$90K	Sell	200 -25	-11%	-$11K	0.01%	405
2020 Q1	$79K	Hold	225	–	–	0.01%	398
2019 Q4	$83K	Hold	225	–	–	0.01%	459
2019 Q3	$75K	Hold	225	–	–	0.01%	465
2019 Q2	$70K	Sell	225 -13	-5%	-$3.89K	0.01%	499
2019 Q1	$73K	Buy	238 +13	+6%	+$3.51K	0.01%	454
2018 Q4	$52K	Hold	225	–	–	﹤0.01%	506
2018 Q3	$70K	Hold	225	–	–	0.01%	513
2018 Q2	$65K	Hold	225	–	–	0.01%	525
2018 Q1	$56K	Hold	225	–	–	0.01%	476
2017 Q4	$54K	Hold	225	–	–	0.01%	507
2017 Q3	$50K	Hold	225	–	–	0.01%	494
2017 Q2	$51K	Hold	225	–	–	0.01%	481
2017 Q1	$45K	Hold	225	–	–	0.01%	553
2016 Q4	$37K	Hold	225	–	–	﹤0.01%	606
2016 Q3	$37K	Sell	225 -145	-39%	-$22K	﹤0.01%	601
2016 Q2	$53K	Buy	370 +25	+7%	+$3.57K	0.01%	507
2016 Q1	$47K	Buy	345 +12	+4%	+$1.57K	0.01%	553
2015 Q4	$46K	Hold	333	–	–	0.01%	506
2015 Q3	$45K	Sell	333 -21	-6%	-$3.02K	0.01%	550
2015 Q2	$53K	Hold	354	–	–	0.01%	531
2015 Q1	$48K	Hold	354	–	–	0.01%	562
2014 Q4	$43K	Buy	354 +3	+0.9%	+$345	0.01%	582
2014 Q3	$40K	Sell	351 -28	-7%	-$3.32K	0.01%	588
2014 Q2	$45K	Buy	379 +151	+66%	+$18.4K	0.01%	575
2014 Q1	$29K	Sell	228 -5	-2%	-$641	﹤0.01%	661
2013 Q4	$29K	Hold	233	–	–	﹤0.01%	618
2013 Q3	$28K	Buy	233 +205	+732%	+$24.2K	﹤0.01%	573
2013 Q2	$3K	Buy	+28	New	+$3.28K	﹤0.01%	771

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

First Horizon Advisors's BIO Position: Q2 2025 in Review

First Horizon Advisors increased its Bio-Rad Laboratories Class A (BIO) stake by 3.4% in Q2 2025, buying an estimated $1.89K and bringing the position to 241 shares worth $58.2K. The position accounts for ﹤0.01% of the portfolio, ranked #920.

First Horizon Advisors first reported a position in BIO in Q2 2013 and has held it in 49 quarters since. The position peaked at $257K in Q2 2022. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

First Horizon Advisors held 241 shares of Bio-Rad Laboratories Class A worth $58.2K as of Q2 2025.
First Horizon Advisors bought 8 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $1.89K.
Bio-Rad Laboratories Class A made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #920 holding.
First Horizon Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 49 quarters since.
First Horizon Advisors's Bio-Rad Laboratories Class A position peaked at $257K in Q2 2022.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.